5 Jul 2026
India

US Woman Says $900 Medicine Costs Just ₹35 in India, Sparks Debate on Healthcare

By GS Team
4 Jul 20262 mins read
TukuTouch Logo
Liz's viral video exposes the shocking medicine price gap: a blood cancer drug costing $900 in the US is just $3 in India. Americans feel "robbed" by their healthcare system, praising India's affordable generic drugs. This sparks global debate on healthcare equity, as more patients share similar experiences, highlighting the US's exorbitant drug costs versus India's accessible treatments.

Summarized by AI; it may make mistakes. Check important info

US Woman Says $900 Medicine Costs Just ₹35 in India, Sparks Debate on Healthcare
Medicine Costs

An American woman named Liz has gone viral on social media after sharing a video comparing the staggering difference in medicine costs between the United States and India. In her Instagram video, titled "Indian vs American Healthcare," she revealed that a single pill of the medication her aunt needs for blood cancer costs around $900 (about ₹85,000) in the US.

In stark contrast, the exact same medicine is available in India for anywhere between ₹35 to ₹300 (30 cents to $3). Liz stated that this massive price gap made her feel that Americans were "being robbed" by their own healthcare system.

Liz explained that her aunt relies on a drug called Revlimid to treat a type of blood cancer. Shocked by the expenses, she verified the global pricing herself, only to discover how incredibly affordable the treatment is in India. According to Liz, India’s robust production of generic medicines allows patients to access life-saving treatments at a fraction of the cost. She went on to praise India's healthcare landscape for ensuring that essential pharmaceuticals remain within reach for ordinary people.

Social Media Reacts to the Price Gap

The video quickly gained traction, racking up more than 772,000 views and sparking intense debates online. Hundreds of users flooded the comment section to agree with Liz, pointing out that the exorbitant cost of prescription drugs in the US is a systemic crisis. Many viewers also highlighted that government hospitals in India frequently provide free or heavily subsidized treatment for life-threatening diseases.

Online reactions varied but shared a common frustration:

  • One user argued that US regulators must do more to crack down on pharmaceutical pricing.
  • Another commented that comprehensive cancer treatment is accessible at minimal cost across Indian public healthcare institutions.
  • Several users admitted to sourcing generic medications directly from India, noting that it remains significantly cheaper than buying them in either the US or Europe.
  • A few even suggested that flying to India to purchase a year's supply of medication would still cost less than paying American retail prices.